Hôpital Rangueil

Running trials

• Not yet recruiting

  French Observatory on the Management of Cardiogenic Shock 2

  NCT07868757· French Cardiology Society· Source

• Not yet recruiting

  Chrono-restricted Diet and Physical Activity as a New Preventive Strategy for Sarcopenia in Postmenopausal Women With Obesity and Type 2 Diabetes

  NCT07075133· University Hospital, Toulouse· Source

• Not yet recruiting

  Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy

  NCT07547033· Assistance Publique - Hôpitaux de Paris· Source

• Not yet recruiting

  Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

  NCT07379957· University Hospital, Bordeaux· Source

• Not yet recruiting

  Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

  NCT06999512· Phase 2/3· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Daiichi Sankyo· Source

• Recruiting

  Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

  NCT06487078· Pfizer· Source

• Recruiting

  Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD

  NCT03593317· Phase 2· Hospices Civils de Lyon· Source

• Recruiting

  Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air

  NCT06614101· University Hospital, Toulouse· Source

• Recruiting

  International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction

  NCT06294028· University Hospital, Toulouse· Source

• Active, not recruiting

  Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06029972· Phase 2· Gilead Sciences· Source

• Recruiting

  PAncreatic Disease Cohort of TOuLouse

  NCT05824403· University Hospital, Toulouse· Source

• Recruiting

  Anatomical-Clinical Base of Adenocarcinoma Pancreatic

  NCT06128343· University Hospital, Toulouse· Source

• Active, not recruiting

  Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation

  NCT05701228· University Hospital, Bordeaux· Source

• Active, not recruiting

  Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

  NCT05817942· Alfasigma S.p.A.· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

  NCT05152147· Phase 3· Jazz Pharmaceuticals· Source

• Active, not recruiting

  Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma

  NCT04791735· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

  NCT04166266· ANRS, Emerging Infectious Diseases· Source

• Recruiting

  Deciphering Mechanisms Underlying Cancer Immunogenicity

  NCT03958240· Institut Claudius Regaud· Source

• Active, not recruiting

  Two Chemotherapy Regimens Plus or Minus Bevacizumab

  NCT03351296· Phase 2· Gustave Roussy, Cancer Campus, Grand Paris· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Pancreatic cancer3 recruiting
• Hepatitis B2 recruiting
• Lung cancer2 recruiting
• Type 2 diabetes2 recruiting
• Amyloidosis1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Glioblastoma1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Liver and biliary tract cancer1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Ventricular tachycardia1 recruiting

Closed trials

• Completed

  Smart MDI Study (CIP343)

  NCT06645834· Medtronic MiniMed, Inc.· Source

• Completed

  Medical and Sociological Characterization of the Population of Patients Admitted for a First Ablation of Atrial Fibrillation in the Occitanie Ouest Region

  NCT06618833· University Hospital, Toulouse· Source

• Completed

  Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

  NCT05525520· Phase 2· Escient Pharmaceuticals, Inc· Source

• Completed

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· Phase 2· Calliditas Therapeutics Suisse SA· Source

• Completed

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· Phase 2· Gilead Sciences· Source

• Completed

  Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

  NCT04469686· Phase 3· Cristcot HCA LLC· Source

• Completed

  Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

  NCT04424303· Pfizer· Source

• Completed

  A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

  NCT04543617· Phase 3· Hoffmann-La Roche· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Completed

  Single-anastomosis Duodeno Ileal Bypass (SADI) Versus Roux-en-Y Gastric Bypass

  NCT03610256· Hospices Civils de Lyon· Source

• Completed

  Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

  NCT02539966· REVA Medical, Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Fabry disease3 works · 0 trials